Preferential inhibition of inducible nitric oxide synthase by ebselen.
Hattori R, Inoue R, Sase K, Eizawa H, Kosuga K, Aoyama T, Masayasu H, Kawai C, Sasayama S, Yui Y.
Hattori R, et al. Among authors: yui y.
Eur J Pharmacol. 1994 Apr 15;267(2):R1-2. doi: 10.1016/0922-4106(94)90179-1.
Eur J Pharmacol. 1994.
PMID: 7519560